{"data":[{"accessionNo":"0001921094-26-000988","issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International, plc","ticker":"KNSA","personName":"Megna Michael R","relationship":"Officer","securityClass":"Class A ordinary shares","broker":"Charles Schwab & Co., Inc.","unitsToSell":4600,"aggregateMarketValue":369380,"unitsOutstanding":48289273,"approxSaleDate":"2026-09-03","exchange":"NASDAQ","filedAt":"2026-09-03"},{"accessionNo":"0001921094-26-000768","issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International, plc","ticker":"KNSA","personName":"Tessari Eben","relationship":"Former Affiliate","securityClass":"Class A Ordinary Shares","broker":"Charles Schwab & Co., Inc.","unitsToSell":67062,"aggregateMarketValue":5347344,"unitsOutstanding":48289273,"approxSaleDate":"2026-07-29","exchange":"NASDAQ","filedAt":"2026-07-29"},{"accessionNo":"0001921094-26-000767","issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International, plc","ticker":"KNSA","personName":"Cole G Bradley","relationship":"Director","securityClass":"Class A Ordinary Share","broker":"Charles Schwab & Co., Inc.","unitsToSell":3673,"aggregateMarketValue":299092,"unitsOutstanding":48289273,"approxSaleDate":"2026-07-29","exchange":"NASDAQ","filedAt":"2026-07-29"},{"accessionNo":"0001921094-25-001502","issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International, plc","ticker":"KNSA","personName":"Ragosa Mark","relationship":"Officer","securityClass":"Class A ordinary shares","broker":"Charles Schwab & Co., Inc.","unitsToSell":72686,"aggregateMarketValue":3015917,"unitsOutstanding":45161019,"approxSaleDate":"2025-12-08","exchange":"NASDAQ","filedAt":"2025-12-08"},{"accessionNo":"0001921094-25-001432","issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International, plc","ticker":"KNSA","personName":"Tessari Eben","relationship":"Officer","securityClass":"Class A Ordinary Shares","broker":"Charles Schwab & Co., Inc.","unitsToSell":48384,"aggregateMarketValue":2075190,"unitsOutstanding":45161019,"approxSaleDate":"2025-11-26","exchange":"NASDAQ","filedAt":"2025-11-26"},{"accessionNo":"0001921094-25-001388","issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International, plc","ticker":"KNSA","personName":"Tessari Eben","relationship":"Officer","securityClass":"Class A Ordinary Shares","broker":"Charles Schwab & Co., Inc.","unitsToSell":12470,"aggregateMarketValue":514225,"unitsOutstanding":45161019,"approxSaleDate":"2025-11-17","exchange":"NASDAQ","filedAt":"2025-11-17"},{"accessionNo":"0001921094-25-001307","issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International, plc","ticker":"KNSA","personName":"Paolini John F.","relationship":"Officer","securityClass":"Class A Ordinary Share","broker":"Charles Schwab & Co., Inc.","unitsToSell":82542,"aggregateMarketValue":3065800,"unitsOutstanding":45161019,"approxSaleDate":"2025-10-31","exchange":"NASDAQ","filedAt":"2025-10-31"},{"accessionNo":"0001921094-25-001299","issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International, plc","ticker":"KNSA","personName":"Ragosa Mark","relationship":"Officer","securityClass":"Class A ordinary shares","broker":"Charles Schwab & Co., Inc.","unitsToSell":20000,"aggregateMarketValue":820000,"unitsOutstanding":43472928,"approxSaleDate":"2025-10-28","exchange":"NASDAQ","filedAt":"2025-10-28"},{"accessionNo":"0001921094-25-001298","issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International, plc","ticker":"KNSA","personName":"Ragosa Mark","relationship":"Officer","securityClass":"Class A ordinary shares","broker":"Charles Schwab & Co., Inc.","unitsToSell":20000,"aggregateMarketValue":820000,"unitsOutstanding":43472928,"approxSaleDate":"2025-10-28","exchange":"NASDAQ","filedAt":"2025-10-28"},{"accessionNo":"0001921094-25-001280","issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International, plc","ticker":"KNSA","personName":"Patel Sanj K","relationship":"Officer, Director","securityClass":"Class A Ordinary Share","broker":"Charles Schwab & Co., Inc.","unitsToSell":257969,"aggregateMarketValue":10035561,"unitsOutstanding":43472928,"approxSaleDate":"2025-10-20","exchange":"NASDAQ","filedAt":"2025-10-20"},{"accessionNo":"0001921094-25-001279","issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International, plc","ticker":"KNSA","personName":"Megna Michael R","relationship":"Officer","securityClass":"Class A ordinary shares","broker":"Charles Schwab & Co., Inc.","unitsToSell":50490,"aggregateMarketValue":1962914,"unitsOutstanding":43472928,"approxSaleDate":"2025-10-20","exchange":"NASDAQ","filedAt":"2025-10-20"},{"accessionNo":"0001921094-25-001257","issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International, plc","ticker":"KNSA","personName":"Tessari Eben","relationship":"Officer","securityClass":"Class A Ordinary Shares","broker":"Charles Schwab & Co., Inc.","unitsToSell":12368,"aggregateMarketValue":465786,"unitsOutstanding":43472928,"approxSaleDate":"2025-10-14","exchange":"NASDAQ","filedAt":"2025-10-14"},{"accessionNo":"0001921094-25-001213","issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International, plc","ticker":"KNSA","personName":"Tessari Eben","relationship":"Officer","securityClass":"Class A Ordinary Shares","broker":"Charles Schwab & Co., Inc.","unitsToSell":42000,"aggregateMarketValue":1609716,"unitsOutstanding":43472928,"approxSaleDate":"2025-09-29","exchange":"NASDAQ","filedAt":"2025-09-29"},{"accessionNo":"0001921094-25-001156","issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International, plc","ticker":"KNSA","personName":"Tessari Eben","relationship":"Officer","securityClass":"Class A Ordinary Shares","broker":"Charles Schwab & Co., Inc.","unitsToSell":16400,"aggregateMarketValue":598016,"unitsOutstanding":43472928,"approxSaleDate":"2025-09-15","exchange":"NASDAQ","filedAt":"2025-09-15"}],"updatedAt":"2026-09-14T17:08:22.464Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data"}